The mechanism of C-type natriuretic peptide production in dogs and its use as a prognostic indicator in critically ill dogs

MOspace/Manakin Repository

Breadcrumbs Navigation

The mechanism of C-type natriuretic peptide production in dogs and its use as a prognostic indicator in critically ill dogs

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/15969

[+] show full item record


Title: The mechanism of C-type natriuretic peptide production in dogs and its use as a prognostic indicator in critically ill dogs
Author: Osterbur, Kara
Keywords: multiple organ dysfunction syndrome
sepsis
C-type natriuretic peptide
diagnostic medicine
biomarker
Date: 2012
Publisher: University of Missouri--Columbia
Abstract: The N-terminal portion of pro C-type natriuretic peptide (NT-pCNP) has shown promise as a diagnostic biomarker for sepsis in humans and dogs. The mechanism of NT-pCNP induction and its use as a prognostic indicator in dogs is unknown. Using a canine aortic endothelial cell culture model, we discovered that NT-pCNP concentrations were significantly greater after lipopolysaccharide, tumor necrosis factor-alpha, and interleukin 1-beta stimulation compared to control and these results were both time and dose dependent in nature. To evaluate NT-pCNP as a prognostic indicator for critically ill dogs, serum NT-pCNP concentrations of critically ill dogs that survived were compared to serum NT-pCNP concentrations of dogs that did not survive. We also evaluated the prognostic capability of serial NT-pCNP concentrations. Serum NT-pCNP concentrations at admission have a sensitivity and specificity of 92% and 65%, respectively for predicting survival in critically ill dogs. To achieve a specificity of 90%, the sensitivity of serum NT-pCNP for prediciting non-survival was only 20%. Evaluation of dynamic changes in serum NT-pCNP concentration over the first three days of hospitalization did not appear to be helpful in predicting outcome. Serum NT-pCNP does not appear to be a promising prognostic biomarker for critically ill dogs.
URI: http://hdl.handle.net/10355/15969
Other Identifiers: OsterburK-072612-T35

This item appears in the following Collection(s)

[+] show full item record